Eli Lilly & Co

LLY78

High Quality

$753.41arrow_drop_up3.16%$23.06

High Quality

S&P500

LLY78

$753.41

arrow_drop_up3.16%$23.06

High Quality

S&P500

Performance History

Key Stats
Open	$735.78
Prev. Close	$729.73
EPS	9.25

Next Earnings Date	Mar 11, 2025

	LOW	HIGH
Day Range	729.82	756.97
52 Week Range	547.60	972.53

Ratios







EPS	9.25

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Eli Lilly & Co (LLY)

Eli Lilly & Co. (LLY) is a global pharmaceutical company that specializes in the development and manufacturing of innovative medicines. With a history that spans over a century, Eli Lilly has established itself as a leader in the healthcare industry, with a strong focus on research and development. The company's mission is to make life better for people around the world through its breakthrough medications. Eli Lilly's portfolio includes a wide range of therapeutic areas, including oncology, diabetes, immunology, and neuroscience.

One of Eli Lilly's key strengths lies in its commitment to innovation. The company invests heavily in research and development, with a goal of bringing new treatment options to patients. Eli Lilly has a strong pipeline of potential new drugs, with several candidates in late-stage clinical trials. This pipeline provides the company with a solid foundation for future growth and sets it apart from its competitors. Additionally, Eli Lilly has a robust portfolio of marketed products, many of which are leaders in their respective therapeutic areas.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—General
CEO: Mr. David A. Ricks
Headquarters: Indianapolis
Employees: 39000
Exchange: NYSE

Keep an eye on Eli Lilly & Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Eli Lilly & Co's (LLY) price per share?

The current price per share for Eli Lilly & Co (LLY) is $753.41. The stock has seen a price change of $23.07 recently, indicating a 3.16% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Eli Lilly & Co (LLY)?

For Eli Lilly & Co (LLY), the 52-week high is $972.53, which is 29.08% from the current price. The 52-week low is $547.61, the current price is 37.58% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Eli Lilly & Co (LLY) a growth stock?

Eli Lilly & Co (LLY) has shown an average price growth of -7.34% over the past three years. It has received a score of 85 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Eli Lilly & Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Eli Lilly & Co (LLY) stock price performance year to date (YTD)?

As of the latest data, Eli Lilly & Co (LLY) has a year-to-date price change of 27.22%. Over the past month, the stock has experienced a price change of -16.85%. Over the last three months, the change has been -20.69%. Over the past six months, the figure is -3.8%. Looking at a longer horizon, the five-year price change stands at 557.37%.

help

Is Eli Lilly & Co (LLY) a profitable company?

Eli Lilly & Co (LLY) has a net income of $5.24B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 79.25% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 39.77% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $34.12B, with a revenue growth rate of 19.56%, providing insight into the company's sales performance and growth. The gross profit is $27.04B. Operating income is noted at $10.33B. Furthermore, the EBITDA is $16.72B.

help

What is the market capitalization of Eli Lilly & Co (LLY)?

Eli Lilly & Co (LLY) has a market capitalization of $716.04B. The average daily trading volume is 749.6, indicating the stock's liquidity and investor engagement.